JP2025505611A5 - - Google Patents

Info

Publication number
JP2025505611A5
JP2025505611A5 JP2024546159A JP2024546159A JP2025505611A5 JP 2025505611 A5 JP2025505611 A5 JP 2025505611A5 JP 2024546159 A JP2024546159 A JP 2024546159A JP 2024546159 A JP2024546159 A JP 2024546159A JP 2025505611 A5 JP2025505611 A5 JP 2025505611A5
Authority
JP
Japan
Prior art keywords
psma
seq
amino acid
acid sequence
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024546159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505611A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/074735 external-priority patent/WO2023147784A1/zh
Publication of JP2025505611A publication Critical patent/JP2025505611A/ja
Publication of JP2025505611A5 publication Critical patent/JP2025505611A5/ja
Pending legal-status Critical Current

Links

JP2024546159A 2022-02-07 2023-02-07 Psmaとcd3に特異的に結合する抗原結合分子及びその医薬的使用 Pending JP2025505611A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210116684.6 2022-02-07
CN202210116684 2022-02-07
PCT/CN2023/074735 WO2023147784A1 (zh) 2022-02-07 2023-02-07 特异性结合psma和cd3的抗原结合分子及其医药用途

Publications (2)

Publication Number Publication Date
JP2025505611A JP2025505611A (ja) 2025-02-28
JP2025505611A5 true JP2025505611A5 (cg-RX-API-DMAC7.html) 2026-02-17

Family

ID=87553110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024546159A Pending JP2025505611A (ja) 2022-02-07 2023-02-07 Psmaとcd3に特異的に結合する抗原結合分子及びその医薬的使用

Country Status (7)

Country Link
US (1) US20250043022A1 (cg-RX-API-DMAC7.html)
EP (1) EP4477669A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025505611A (cg-RX-API-DMAC7.html)
KR (1) KR20240139065A (cg-RX-API-DMAC7.html)
CN (2) CN118574855B (cg-RX-API-DMAC7.html)
TW (1) TW202337902A (cg-RX-API-DMAC7.html)
WO (1) WO2023147784A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025031285A1 (zh) * 2023-08-04 2025-02-13 江苏恒瑞医药股份有限公司 抗psma抗体-药物偶联物及其医药用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
EP0979281B1 (en) 1997-05-02 2005-07-20 Genentech, Inc. A method for making multispecific antibodies having heteromultimeric and common components
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
KR100797667B1 (ko) 1999-10-04 2008-01-23 메디카고 인코포레이티드 외래 유전자의 전사를 조절하는 방법
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
US7514078B2 (en) * 2001-06-01 2009-04-07 Cornell Research Foundation, Inc. Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
KR101374454B1 (ko) 2005-03-31 2014-03-17 추가이 세이야쿠 가부시키가이샤 회합제어에 의한 폴리펩티드 제조방법
DK1999154T3 (da) 2006-03-24 2012-12-03 Merck Patent Gmbh Fremstillede heterodimere proteindomæner
WO2007147901A1 (en) 2006-06-22 2007-12-27 Novo Nordisk A/S Production of bispecific antibodies
EP3663318A1 (en) 2008-01-07 2020-06-10 Amgen Inc. Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
US9067986B2 (en) 2009-04-27 2015-06-30 Oncomed Pharmaceuticals, Inc. Method for making heteromultimeric molecules
US20130089554A1 (en) 2009-12-29 2013-04-11 Emergent Product Development Seattle, Llc RON Binding Constructs and Methods of Use Thereof
WO2011143545A1 (en) 2010-05-14 2011-11-17 Rinat Neuroscience Corporation Heterodimeric proteins and methods for producing and purifying them
CN103429620B (zh) 2010-11-05 2018-03-06 酵活有限公司 在Fc结构域中具有突变的稳定异源二聚的抗体设计
US9527927B2 (en) 2011-12-20 2016-12-27 Medimmune, Llc Modified polypeptides for bispecific antibody scaffolds
WO2013157953A1 (en) 2012-04-20 2013-10-24 Merus B.V. Methods and means for the production of ig-like molecules
EA201792442A1 (ru) * 2015-05-06 2018-06-29 Янссен Байотек, Инк. Биспецифические агенты, связывающие простатический специфический мембранный антиген (psma), и их применение
AR107582A1 (es) 2016-02-03 2018-05-16 Amgen Res Munich Gmbh Constructos de anticuerpo biespecíficos para psma y cd3 que se ligan a células t
KR20190014525A (ko) * 2016-05-27 2019-02-12 애브비 바이오테라퓨틱스 인크. 면역 조절 단백질과 종양 항원을 결합하는 이중특이적 결합 단백질
US11773182B2 (en) * 2017-01-05 2023-10-03 The Johns Hopkins University Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA)
JP7599205B2 (ja) * 2018-06-01 2024-12-13 アンヘレス セラピューティクス インコーポレイテッド 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化
EP3936526A4 (en) 2019-03-06 2023-03-08 Jiangsu Hengrui Pharmaceuticals Co., Ltd. BIFUNCTIONAL FUSION PROTEIN AND PHARMACEUTICAL USE THEREOF
EP3986933A1 (en) * 2019-06-21 2022-04-27 Regeneron Pharmaceuticals, Inc. Use of bispecific antigen-binding molecules that bind psma and cd3 in combination with 4-1bb co-stimulation
EP4089111A4 (en) 2020-01-09 2023-10-04 Jiangsu Hengrui Medicine Co., Ltd. NEW POLYPEPTIDE COMPLEX

Similar Documents

Publication Publication Date Title
JP2024532485A5 (cg-RX-API-DMAC7.html)
KR101974901B1 (ko) 교차 결합 영역 배향을 갖는 이원 가변 영역 항체-유사 결합 단백질
CA2773515C (en) Bispecific death receptor agonistic antibodies
JP2023178323A5 (cg-RX-API-DMAC7.html)
JP2022079549A5 (cg-RX-API-DMAC7.html)
JP2021524268A5 (cg-RX-API-DMAC7.html)
JP2021524267A5 (cg-RX-API-DMAC7.html)
JP2021524269A5 (cg-RX-API-DMAC7.html)
JP2023123726A5 (cg-RX-API-DMAC7.html)
JP2023548045A5 (cg-RX-API-DMAC7.html)
KR20180012860A (ko) 이종 이량체 다중 특이적 항체 포맷
IL272747B1 (en) Bispecific antibodies 1 + 2
JP2023545057A5 (cg-RX-API-DMAC7.html)
KR20140067944A (ko) 항체 중쇄불변부위의 이종이중체 고효율 형성을 유도하는 ch3 도메인 변이체 쌍, 이의 제조방법, 및 용도
CN111378044B (zh) 抗体融合蛋白、制备方法及其应用
JP2019501883A5 (cg-RX-API-DMAC7.html)
IL292780A (en) A new 4-1bbl trimer containing antigen-binding molecules
JP2018526981A5 (cg-RX-API-DMAC7.html)
CN108699136A (zh) 结合cd3和psma的异二聚抗体
WO2007095338A2 (en) Functional antibodies
WO2013064701A2 (en) Bispecific antibodies and methods for isolating same
US20200277366A1 (en) MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A and IL-17F
JP2025160226A5 (cg-RX-API-DMAC7.html)
JP2020502233A5 (cg-RX-API-DMAC7.html)
JP2025512865A5 (cg-RX-API-DMAC7.html)